Key Findings
The Europe dry eye disease market is predicted to project a CAGR of 4.79% during the forecast period, 2023-2032. Factors such as the growing awareness regarding dry eye disease, the increasing prevalence of glaucoma, the rising geriatric population, and the surging market consolidation are predominately credited to the region’s market growth.

Market Insights
Poland, Spain, France, the United Kingdom, Germany, Belgium, Italy, and Rest of Europe are assessed for the Europe dry eye disease market growth evaluation. Italy harbors an advanced healthcare industry, representing a significant market. Glaucoma, as well as retinal disorders, encompass the largest segments. However, dry eye disease is relatively smaller, with no insurance reimbursement offered for the treatment of the same. The Italian Medicines Agency (Agenzia italiana del farmaco, AIFA) is the public institution in the country overlooking the regulatory activities of pharmaceuticals. Further, dry eye disease is more frequent among women in Italy, increasing with age.
In Belgium, the Federal Agency for Medicines and Health Products (FAMHP) oversees the quality, efficacy, and safety of health products and medicines for veterinary and human use and clinical developments. In addition, according to World Health Organization (WHO) stats, health expenditure raised in the past two decades. Furthermore, the presence of ophthalmic clinics boosts the analyzed market’s demands in Belgium.
Whereas in Spain, the increasing healthcare expenditure on pharmaceutical development enables growth opportunities. Besides, approximately 42% of the population will be aged above 60 by 2050.

Competitive Insights
Leading firms operating in the market are Johnson & Johnson, VISUfarma, Novartis AG, etc.
Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation caters to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments